Anti-TNFRSF10B/TRAILR2/CD262 Antibody (Tilogotamab)
Catalog No.
F1514
Anti-TNFRSF10B/TRAILR2/CD262 Antibody (Tilogotamab)
Featured Products
Tilogotamab (GEN-1029) is an agonistic hexamer-enhanced mixture of two antibodies that target two independent epitopes on death receptor type 5 (DR5). Tilogotamab specifically binds to and activates DR5. Tilogotamab can be used in the study of multiple myeloma (MM).
Quality Control & DataSheet
- View current batch:
-
Purity > 95% by SDS-PAGE and SEC-HPLC analyses.
- MSDS (Material Safety Data Sheet)
- Datasheet
145.18 kDa
Dry ice
2109731-10-2
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
tilogotamab
100 mM Pro 20 mM Arg pH 5.0. No preservative!
O14763
Human
Unconjugated
Monoclonal
Protein A
IgG1
ELISA, FACS, Kinetics, Functional assay, Animal Model
TNFRSF10B / TRAILR2 / CD262
Please avoid freeze-thaw cycles.